49

Listed companies

49

Private companies

306

Insiders

Relation chart of related listed companies: Novo Nordisk A/S

Active Relations

Past Relations

Related listed companies: Novo Nordisk A/S

Active Relations

Past Relations

Relationship chart for related private companies: Novo Nordisk A/S

Active Relations

Past Relations

Related private companies: Novo Nordisk A/S

Novo Nordisk Pharma GmbH

Novo Holdings A/S (Denmark)

Financial Conglomerates

Ferring Pharmaceuticals A/S

Pharmaceuticals: Major

William Demant Invest A/S

Investment Managers

Bioneer A/S

Pharmaceuticals: Major

University of Copenhagen

Other Consumer Services

Hempel A/S

Industrial Specialties

Forbion Capital Partners Management Holding BV

Investment Managers

European Federation of Pharmaceutical Industries & Assns

Miscellaneous Commercial Services

Novo Nordisk, Inc.

Biotechnology

2cureX ApS

Pharmaceuticals: Major

RSP Systems A/S

Medical Specialties

Helion Biotech ApS

Pharmaceuticals: Major

Dansk Biotek

Miscellaneous Commercial Services

Novo Nordisk Region Aameo & Latam A/S

Financial Conglomerates

Medicon Valley Alliance FMBA

Miscellaneous Commercial Services

Nuvelution Pharma, Inc.

World Diabetes Foundation

Novo Holdings A/S (Investment Company)

Eir Ventures Partners AB

Momentum Energy Group A/S

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major16
Medical Specialties8
Biotechnology4
Financial Conglomerates3
Miscellaneous Commercial Services3
Drugstore Chains2
Chemicals: Specialty2
Investment Managers2
Investment Trusts/Mutual Funds1
Information Technology Services1

Countries of related companies

Denmark56
Sweden15
United States9
Switzerland3
Netherlands2
Germany2
France2
Belgium2
Italy1
Poland1
Logo Novo Nordisk A/S
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).
Employees
78,554
More about the company